Christopher Poremba

Medicine · Health Sciences

56h-index10.0kcitations253works1.32yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(56), Cancer, Hypoxia, and Metabolism(33), Neuroblastoma Research and Treatments(28), RNA modifications and cancer(26), Cancer-related Molecular Pathways(16)

Publications253 total

Prostate Carcinoma: Hereditary and Predictive Aspects of Molecular Pathology
Trillium Pathology·2025Open Access
Molecular subtyping of head and neck cancer – Clinical applicability and correlations with morphological characteristics
Oral Oncology·2024· 4 citedOpen Access
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
British Journal of Cancer·2024Open Access
Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients
Cancers·2023· 3 citedOpen Access
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
British Journal of Cancer·2023· 26 citedOpen Access
Data from Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy
2023Open Access
Supplementary Table 1 from Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy
2023Open Access
Supplementary Figure 1 from Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy
2023Open Access
Supplementary Table 1 from Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy
2023Open Access
Supplementary Figure 1 from Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy
2023Open Access
Data from Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy
2023Open Access
Supplementary Table 8a from Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells <i>In vitro</i>
2023Open Access
Supplementary Table 9 from Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells <i>In vitro</i>
2023Open Access
Supplementary Table 2 from Expression Profiling of t(12;22) Positive Clear Cell Sarcoma of Soft Tissue Cell Lines Reveals Characteristic Up-Regulation of Potential New Marker Genes Including <b><i>ERBB3</i></b>
2023Open Access
Supplementary Table 8b from Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells <i>In vitro</i>
2023Open Access
Data from Expression Profiling of t(12;22) Positive Clear Cell Sarcoma of Soft Tissue Cell Lines Reveals Characteristic Up-Regulation of Potential New Marker Genes Including <b><i>ERBB3</i></b>
2023Open Access
Supplementary Figure 1 from Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells <i>In vitro</i>
2023Open Access
Supplementary Figure Legend 1, Table Legends 1-6 from Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells <i>In vitro</i>
2023Open Access
Supplementary Figure 1 from Activation of Akt Predicts Poor Outcome in Neuroblastoma
2023Open Access
Supplementary Tables 1-6 from Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells <i>In vitro</i>
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Karl‐Ludwig Schaefer(15), Raihanatou Diallo(14), Werner Boecker(12), Barbara Dockhorn‐Dworniczak(10), Daniel Wai(10), Horst Buerger(8), C. Brinkschmidt(6), Wolfram Domschke(5), Yvonne Braun(5), Ronald Simon(4), Heribert Juergens(4), W. Böcker(3), Hermann Herbst(3), Winfried Winkelmann(3), Pancras C.W. Hogendoorn(3), Heinrich Kovar(3), F. van Valen(3), Helmut E. Gabbert(3), Achim Heinecke(3), Ágnes Bánkfalvi(3)